baber/WOPTO huggingface dataset:
Patent CA-2890513-A1 (CA)
Title: Procede pour une reduction de champ arriere dans des systemes de surveillance d'article electronique (eas)
Inventor: BERGMAN ADAM S
IPC: G08B13/24
Filed: 2013-05-17
Abstract: La présente invention porte sur un procédé pour réduire des alarmes non souhaitées dans un système de surveillance d'article électronique (EAS), qui implique la mesure d'une réponse d'étiquette au niveau d'un premier et d'un second piédestal pour obtenir des première et seconde réponses d'étiquette simultanées. Les réponses d'étiquette sont comparées pour évaluer une intensité de signal relative et ainsi discerner une réponse d'étiquette d'intensité de signal moins importante. Un signal de commande d'excitateur de niveau réduit est appliqué à un piédestal sélectionné parmi les premier et second piédestaux associés à la réponse d'étiquette d'intensité de signal moins importante. Une zone de détection est ensuite surveillée pour déterminer l'occurrence d'une troisième réponse d'étiquette résultant du signal d'excitateur de niveau réduit. L'emplacement approximatif de l'étiquette par rapport aux premier et second piédestaux est déterminé sur la base des première, seconde et troisième réponses d'étiquette.
Patent CA-2892478-A1 (CA)
Inventor: DESROCHE NICOLAS
IPC: A61P31/00
Filed: 2013-12-13
Abstract: La présente invention a pour objet une bactérie ou un mélange de bactéries ayant une activité antagoniste vis-à-vis des souches à S. aureus, P. aeruginosa, Streptococcus pyogenes, Enterococcus faecium, Enterobacter cloacae, Proteus mirabilis, Bacteroides fragilis Staphylococcus epidermidis, Propionibacterium acnés, Candida albicans et/ou Malassezia furfur ainsi que son utilisation dans le traitement et/ou la prévention des infections ou colonisation liées à ces pathogènes. L'invention concerne des produits de soins contenant une ou plusieurs souches antagonistes non pathogènes destinée(s) à la prévention, au traitement des infections ou colonisations au niveau de la peau, la plaie, des muqueuses et des phanères..
Patent CA-2894245-A1 (CA)
Inventor: UGER ROBERT ADAM
IPC: C07K14/705
Filed: 2013-12-17
Abstract: CD47+ disease cells, such as CD47+ cancer cells, are treated with an agent that blocks signalling via the SIRPa/CD47 axis. The agent is a human SIRPa fusion protein that displays negligible CD47 agonism and negligible red blood cell binding. The fusion protein comprises an IgV domain from variant 2 of human SIRPa, and an Fc having effector function. The IgV domain binds human CD47 with an affinity that is at least five fold greater than the affinity of the entire extracellular region of human SIRPa. The fusion protein is at least 5 fold more potent than a counterpart lacking effector function.
Patent CA-2896566-A1 (CA)
Inventor: HERZEL RONI
IPC: H04N5/63
Filed: 2013-11-17
Abstract: Disclosed is a system apparatus and device for facilitating the backup of network edge devices, such as video cameras, and methods of operation thereof. A monitoring circuit(s) may detect inoperable electrical power condition(s) (IEPC) on the power-line of a network edge device. Upon detection of an IEPC a backup power source may provide electrical power to the edge device. Upon detection of a connectivity fault between the edge device and its packet sink, a packet sink emulator may emulate a packet sink of the edge device.
Patent CA-2899701-A1 (CA)
Title: Utilisation d'une composition comprenant un perseose d'avocat dans la protection des cellules souches epidermiques
Inventor: MSIKA PHILIPPE
IPC: A61P35/00
Filed: 2014-02-11
Abstract: L'invention a pour objet une utilisation des sucres en C7 et dérivés de formule (I), appelés perséose d'avocat qui, présentent, entre autres, une activité protectrice des cellules souches épidermiques. Ces sucres en C7 et dérivés sont capables de maintenir l'expression des marqueurs de cellules souches adultes, notamment les cellules souches basales. Le perséose d'avocat permet ainsi de prévenir les effets délétères des agressions environnementales. Le perséose d'avocat a un effet bénéfique sur la conservation du potentiel des cellules souches épidermiques et, ainsi, contribue à maintenir l'homéostasie de la peau.
Patent CA-2904095-A1 (CA)
Inventor: DIEHL LAURI
IPC: G01N33/00
Filed: 2014-03-26
Abstract: Methods of assessing or monitoring the effect, efficacy, responsiveness to treatment, and/or determining a dose or dosing regimen of therapeutic agents, such as integrin beta7 antagonists, for the treatment of gastrointestinal inflammatory disorders are provided. In certain aspects, methods of using integrin beta7 subunit-containing receptor occupancy by the integrin beta7 antagonist on colonic lymphocytes as an indicator ("biomarker") of the effect, efficacy, or responsiveness to treatment, and/or as a means to determine dosing or dosing regimens of therapeutic agents such as beta7 integrin antagonists for the treatment of gastrointestinal inflammatory disorders are provided. In certain aspects, methods of assessing the effect, efficacy, or responsiveness to beta7 integrin antagonist treatment by measuring gene expression levels of one or more integrin receptor ligands, lymphocyte genes, cytokine genes, or the number of alphaE-positive cells in intestinal crypt epithelium are provided.
Patent CA-2904651-A1 (CA)
Title: Slim profile loudspeaker
Inventor: FINCHAM LAWRENCE R
IPC: H04R1/02
Filed: 2014-03-10
Abstract: A narrow-profile balanced subwoofer or similar speaker includes a number of drivers placed side by side in the same lateral plane, with a first set of drivers facing one direction and second set of drivers facing the opposite direction. Their orientation is such that the sum of the forces from the first set of drivers is equal and opposite the sum of the forces from the second set of drivers, thus cancelling, and the sum of the moments from all of the drivers about a center or pivot point substantially equals zero. The speaker may include three or more drivers, symmetrically or asymmetrically spaced. The drivers may be of the same or different sizes, and the audio signal amplitudes may be adjusted to help balance the speaker. Each set of drivers may output sound into separate sound ducts, which may output sound from one or more apertures.
Patent CA-2905619-A1 (CA)
Title: Extracorporeal life support system and methods of use thereof
Inventor: PARTRIDGE EMILY
IPC: A61M1/16
Filed: 2014-03-17
Abstract: Extracorporeal membrane oxygenation systems and methods of use are disclosed. Several publications and patent documents are cited throughout the specification in order to describe the state of the art to which this invention pertains. Full citations of these references can be found throughout the specification. Each of these citations is incorporated herein by reference as though set forth in full.
Patent CA-2905624-A1 (CA)
Inventor: GAIN PHILIPPE
IPC: A01N1/02
Filed: 2013-03-14
Abstract: Un dispositif (1) médical de conservation d'un prélèvement cornéen (3) comprend des moyens de réception et d'emprisonnement de le prélèvement cornéen, assujettis à des moyens de création d'un gradient de pression avec surpression du coté endothélial et à des moyens de circulation d'un liquide de conservation dans des agencements que présentent les moyens de réception et d'emprisonnement. Les moyens de réception et d'emprisonnement emprisonnent de manière étanche la collerette de sclère qui entoure la cornée pour délimiter une chambre endothéliale et une chambre épithéliale séparées dans lesquelles peut circuler du milieu de conservation avec une surpression dans la chambre endothéliale. La pièce intermédiaire (2), et le couvercle endothélial (4), comprennent des orifices d'entrée et de sortie de milieu de conservation auxquels sont reliés les moyens de mise en circulation du milieu de conservation et de création du gradient de pression entre chambre endothélial et chambre épithéliale avec surpression dans la chambre endothéliale. De préférence, le dispositif comprends un couvercle épithélial (5) permettant une applanation réglable.
Patent CA-2906352-A1 (CA)
Title: Double compression set packer
Inventor: DERBY MICHAEL C
IPC: E21B33/12
Filed: 2014-03-11
Abstract: A device and method allow a longer sealing element to be used on a packer or other downhole tool while providing an increase in the total amount of setting force that can be used and providing for more uniform or balanced setting of the sealing element. The packer may be first set using internal bore pressure to radially expand one end of the sealing element with a first hydraulic setting mechanism. The packer may then be set a second time using annulus pressure to continue the radial expansion of the sealing element with a second hydraulic setting mechanism.
Patent CA-2907082-A1 (CA)
Title: Methods for treating inflammation, autoimmune disorders and pain
Inventor: SAVAGE PAUL B
IPC: C07D471/04
Filed: 2014-03-13
Abstract: Disclosed herein are methods of treating, reducing, or preventing a disease or symptom such as oral mucositis, gingivitis, periodontitis, gastric mucositis, gastritis, colitis, ileitis, Crohn's disease, chronic inflammatory intestinal disease, inflammatory bowel syndrome, chronic inflammatory bowel disease, celiac disease, ulcerative colitis, a gastric ulcer, a peptic ulcer, a buccal ulcer, a nasopharyngeal ulcer, an esophageal ulcer, a duodenal ulcer, a gastrointestinal ulcer, cystic fibrosis, an autoimmune disorder, or pain, comprising identifying a patient in need of treatment and administering a therapeutically effective amount of at least one cationic steroid antimicrobial (CSA), or a pharmaceutically acceptable salt thereof. Kits comprising such compositions and instructions on such methods are also contemplated herein.
Patent CA-2912908-A1 (CA)
Title: Agents cytotoxiques destines au traitement du cancer
Inventor: LEVITT DANIEL
IPC: A61P35/00
Filed: 2014-06-04
Abstract: La présente invention concerne une méthode de traitement d'un cancer du cerveau, comprenant l'administration d'une substance thérapeutiquement efficace à un patient. Ladite substance thérapeutiquement efficace comprend (I) ou son sel pharmaceutiquement acceptable, X étant une fraction qui peut être clivée hydroliquement ou enzymatiquement dans le corps du patient d'une manière dépendante du pH.
Patent CA-2913691-A1 (CA)
Inventor: MC GOWAN DAVID CRAIG
IPC: A61P37/04
Filed: 2014-07-29
Abstract: This invention relates to thieno[3,2-d]pyrimidinesderivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.
Patent CA-2915200-A1 (CA)
Inventor: HALLAS GREGORY
IPC: D21F3/02
Filed: 2015-12-15
Abstract: The problem of deck channel rewetting that occurs when a drainage chamber in a roll upwardly approaches a horizontal line extending past the horizontal diameter of the roll is solved by using a comb plate comprising at least one comb tooth engaging the perforated plate and extending through a deck channel to a drainage channel such that the at least one comb tooth has a slope configured to direct a slurry suspension from the perforated plate into the drainage channel.
Patent CA-2916470-A1 (CA)
Title: Fluid volume measurement using canister resonance for reduced pressure therapy systems
Inventor: LUCKEMEYER JAMES A
IPC: G01N29/036
Filed: 2014-06-25
Abstract: A wound fluid collection system includes a canister adapted to collect bodily fluids from a tissue site. The canister includes an acoustic transducer adapted and positioned to insonify a cavity within the canister, the cavity being defined by a wall of the canister and the bodily fluids collected within the canister. A resonant frequency may be calculated based on a resulting received signal from the insonification. The resonant frequency may indicate a volume of the cavity within the canister. The difference between a known volume of the canister and the calculated volume of the cavity provides the volume of bodily fluid collected in the canister.
Patent CA-2916937-A1 (CA)
Title: Dna element having the activity of enhancing foreign gene expression
Inventor: NISHIMIYA DAISUKE
IPC: C12P21/02
Filed: 2011-07-06
Abstract: Disclosed is a method for stably achieving high expression of a foreign gene in mammalian cells using a novel DNA  element. More specifically disclosed is a DNA element which enhances the activation of transcription by changing the chromatin structure around a gene locus into which a foreign gene expression unit has been introduced.
Patent CA-2917474-A1 (CA)
Title: Base for hot-fill plastic containers
Inventor: KELLEY PAUL V
IPC: B65D1/02
Filed: 2014-07-02
Abstract: A base structure for a blow-molded container (10) having an annular sidewall (6) and a central longitudinal axis (100), the base structure comprising: a bottom portion (2); an annular support heal positioned between the sidewall (6) and the bottom portion (2), wherein the annular support heal is angled inwardly at an angle ? of from about 15° to about 46° relative a plane extending from the sidewall (6); and a first rounded edge (4) between the sidewall (6) and the annular support heal and a second rounded edge (5) between the annular support heal and the bottom portion, wherein each of the first and second rounded edge has a radius of curvature of from about 1.0 mm to about 14.0 mm, and wherein the blow-molded container comprises a material selected from the group consisting of polyethylene terephthalate and polypropylene.
Patent CA-2920464-A1 (CA)
Inventor: KUSTER HANS-WERNER
IPC: E06B3/673
Filed: 2014-08-22
Abstract: The present invention relates to a spacer for an insulating glazing unit composed of at least two glass panes. The spacer comprises at least one polymeric basic body, which comprises at least two mutually parallel side walls connected to each other by an inner wall and an outer wall, wherein the side walls, the inner wall, and the outer wall surround a hollow chamber. The spacer also comprises at least on the outer wall, an insulation film, which contains a polymeric carrier film and at least one metallic or ceramic layer.  In the spacer, a reinforcing strip, which contains at least one metal or one metallic alloy, is embedded in each side wall.
Patent CA-2921780-A1 (CA)
Inventor: MOSANER KNUD
IPC: B60D5/00
Filed: 2016-02-24
Abstract: The object of the invention is a gangway (4) between two articulately connected vehicles (1, 2) comprising at least one bellows (10) enveloping a gangway system in the manner of a tunnel, wherein the bellows (10) has several circumferential bellows frames (12), also tunnel-shaped, for forming corrugations or folds, wherein the bellows (10) has spacers, in the floor or roof area, between individual bellows frames (12) of the corrugations or folds and between a bellows frame and a fixed point connected to the respective vehicle.
Patent CA-2922978-A1 (CA)
Title: Elevation conveyance system and method
Inventor: MCSWAIN R KEVIN
IPC: B66F9/00
Filed: 2014-09-05
Abstract: An elevation conveyance system for transporting a payload substantially vertically and transversely to a preselected release location. The system includes a track assembly comprising a substantially vertical track, one or more bin assemblies in which the payload is receivable, and one or more car assemblies configured for movement along the track. The car assembly includes a housing subassembly having a means for engaging the track to permit movement of the car assembly along the track, and a conveyor subassembly for transporting the payload substantially transversely relative to the track. The bin assembly is receivable in the housing subassembly and configured to release the payload onto the conveyor subassembly for substantially transverse transportation of the payload to the preselected release location.
Patent CA-2923050-A1 (CA)
Title: Therapie hyperoxique avec un modele de reponse a la dose d'oxygene
Inventor: PETERSON RUSSELL E
IPC: A61G10/02
Filed: 2014-09-03
Abstract: La présente invention concerne des systèmes, des procédés et un appareil pour appliquer un système d'administration de thérapie hyperoxique à un patient ; l'administration de gaz hyperoxique au patient conformément à un modèle de réponse à la dose d'oxygène ; et l'ajustement de l'administration du gaz hyperoxique au patient en fonction de paramètres contrôlés liés à une affection du patient. L'invention concerne également de nombreux autres aspects.
Patent CA-2924805-A1 (CA)
Title: Heating device for spectrometry measurement apparatus
Inventor: NESA GUILLAUME
IPC: G01N33/497
Filed: 2014-09-18
Abstract: The invention relates to a heating device for a spectrometry measurement apparatus characterized in that it takes the form of a supple optical item (1), which item comprises a supple flexible support (10) having a top face (10a) and a bottom face (10b), the top face (10a) being covered with a reflective material (11) to form an optically reflective layer, a flexible heating element (13) being arranged on at least one of said faces of the support.
Patent CA-2925320-A1 (CA)
Title: Collecteurs et leurs procedes d'utilisation pour reguler des ecoulements de fluide
Inventor: TIPLER ANDREW
IPC: G01N30/62
Filed: 2014-09-29
Abstract: L'invention concerne, dans certains modes de réalisation, des dispositifs pouvant être utilisés pour réguler des écoulements de fluide traversant un ou plusieurs détecteurs. Dans certaines configurations, le dispositif peut être configuré sous la forme d'un collecteur pouvant recevoir une pression positive pour dissocier l'écoulement de fluide traversant une colonne de chromatographie d'un écoulement de fluide traversant un détecteur. Dans certaines configurations, un écoulement d'échantillon peut être introduit de manière accélérée dans une cellule de détecteur comprenant un ou plusieurs filaments.
Patent CA-2928012-A1 (CA)
Inventor: GROSVELD FRANK
IPC: C12Q1/68
Filed: 2014-11-18
Abstract: The present invention provides a method for analysing the interaction of one or more nucleotide sequence(s) from one or more region(s) of interest with other nucleotides sequences in a three-dimensional DNA structure, comprising the steps of: (a) providing a sample of cross-linked DNA; (b) digesting the cross-linked DNA with a first restriction enzyme; (c) ligating the cross-linked nucleotide sequences; (d) reversing the cross-linking; e) fragmenting the ligated molecules from (d); (f) hybridising the fragments from (e) to one or more oligonucleotides representing the sequences which are adjacent to the cleavage site of the first restriction enzyme in order to enrich for the ends of the nucleotide sequences that have been ligated to another nucleotide sequence in step (c); and (g) analysing the nucleotide sequence of the enriched fragments in order to identify the nucleotide sequences involved in interaction(s).
Patent CA-2931085-A1 (CA)
Inventor: DIXON DARRYL DAVID
IPC: A61P35/00
Filed: 2014-12-15
Abstract: The present disclosure relates to cyclic sulfones and sulfoximines that are HIF-2a inhibitors and methods of making and using them for treating cancers. In another aspect, the present disclosure provides a pharmaceutical composition comprising a compound described herein and a pharmaceutically acceptable carrier or excipient. The compound may exist in an amorphous form, a crystalline form, or as a salt, solvate, or hydrate. In another aspect, the present disclosure provides a method of treating renal cell carcinoma by administrating a therapeutically effective amount of a compound described herein or a pharmaceutical composition thereof to a subject in need of such treatment.
Patent CA-2931788-A1 (CA)
Inventor: LEWIS BRYAN M
IPC: C07D493/22
Filed: 2014-12-05
Abstract: In general, the present invention features improved methods useful for the synthesis of analogs of halichondrin B, such as eribulin and pharmaceutically acceptable salts thereof (e.g., eribulin mesylate).
Patent CA-2932688-A1 (CA)
Title: Fiber optic assemblies for tapping live optical fibers in fiber optic networks employing parallel optics
Inventor: BUFF SCOTT EAKER
IPC: G02B6/44
Filed: 2014-12-01
Abstract: A fiber optic assembly for supporting optical connections in a fiber optic network employing parallel optical configurations is described. In one embodiment, the fiber optic assembly includes at least two live multi-fiber components and at least one tap multi-fiber component. Optical signals are routed from one live multi-fiber component to another in a parallel optical connection configuration, with each group of optical signals corresponding to a respective group of fiber positions on each live multi-fiber component. Each group of optical signals is also routed to one of the first and second groups of fiber positions of the at least one tap multi-fiber component in a parallel optical connection configuration. In this manner, fiber optic signals can be simultaneously provided and monitored within an active fiber optic network using a parallel optical configuration without the need for interrupting network operations.
Patent CA-2933641-A1 (CA)
Title: Control of carbonyl sulfide with sodium borohydride in caustic towers for petroleum/petrochemical processes
Inventor: MO HUA
IPC: B01D53/48
Filed: 2016-06-17
Abstract: Sodium borohydride (NaBH4) may be used to removing carbonyl sulfide (COS) from a process stream containing it. The method involves contacting the process stream with an amount of effective of NaBH4 to react with the COS to form reaction products that may be removed by a process of washing away the reaction product by an aqueous basic compound and/or the reaction product having a higher boiling point than carbonyl sulfide which permits trapping the reaction product, such as in a caustic tower.
Patent CA-2933813-A1 (CA)
Title: Methods for obtaining data from a subterranean formation
Inventor: NGUYEN PHILIP D
IPC: E21B49/00
Filed: 2014-02-18
Abstract: Various embodiments disclosed relate to methods of obtaining data from a subterranean formation and systems for performing the method. In various embodiments, the present invention provides a method of obtaining data from a subterranean formation including obtaining or providing first proppant particles and second proppant particles. The first proppant particles can have a particle size of about 0.2 mm to about 10 mm. The second proppant particles can have a particle size of about 0.010 m to about 199 m. The method can include placing the first and second proppant particles into a subterranean formation. In the subterranean formation, at least part of at least one of the first and second proppant particles can be electroconductive proppant particles. The method can include transmitting at least one of an electric current and an electromagnetic signal to at least part of the electroconductive proppant particles. The method can also include detecting at least one of an electric current and an electromagnetic signal at least partially reflected by or conducted through the electroconductive proppant particles.
Patent CA-2935294-A1 (CA)
Inventor: OWUSU OSEI
IPC: C08J5/18
Filed: 2014-12-10
Abstract: Printing layers and films for printing are disclosed. Methods for preparing such films also are disclosed.
Patent CA-2936078-A1 (CA)
Inventor: LUXON EVAN S
IPC: A61M27/00
Filed: 2015-01-07
Abstract: A device for draining bodily fluids is described herein which generally may comprise an elongate body defining one or more lumens configured to receive a bodily fluid from a cavity, e.g., bladder, of a patient body. The one or more lumens are in fluid communication with a reservoir which may receive the bodily fluid. A pumping mechanism may be used to urge the bodily fluid through the one or more lumens, where the pumping mechanism is configured to maintain an open space within the one or more lumens such that outflow of the bodily fluid through the one or more lumens remains unobstructed such that a negative pressure buildup in the cavity is inhibited. The device may also include a vent or valve mechanism in communication with the elongate body to allow air to enter or exit the one or more lumens.